RecruitingNot Applicable

LA PrEP Impact and Cost-effectiveness (TEAMS)

Thailand10,720 participantsStarted 2022-03-15

Plain-language summary

This study will have three components: 1. Discrete choice experiments 2. Analysis of routine service data 3. Impact and cost-effectiveness analyses using results from 1 and 2

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Minimum age of 18 years * Individual assigned male at birth reporting sex with men in the past 12 months * Self-reported HIV-negative MSM and TGW who either report interest in PrEP use, current PrEP use, or past PrEP use * Permit audio recording during the interview and/or discussion. Exclusion Criteria: * Not willing to participate in the study

What they're measuring

The epidemiological impact of long-acting antiretrovirals for HIV prevention among Thai MSM and TGW at risk of HIV infection

Timeframe: 12 months

The cost-effectiveness of long-acting antiretrovirals for HIV prevention among Thai MSM and TGW at risk of HIV infection

Timeframe: 12 months

Trial details

NCT IDNCT05774548

SponsorInstitute of HIV Research and Innovation Foundation, Thailand

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-15

Contact for this trial

Nittaya Phanuphak, MD,PhD.

6681 825 3544 nittaya.p@ihri.org

View on ClinicalTrials.gov More Hiv trials